Eisai Selects Medidata’s Clinical Data Studio to Enhance and Modernize Clinical Trial Efficiency and Patient Experience
AI-enhanced solution will help Eisai accelerate data review and reconciliation by 80%
| ABX | ||
| 3,060.339 | ||
| 15.2480 | 0.0050% | |
| BISNIS-27 | ||
| 411.225 | ||
| -1.8130 | -0.0044% | |
| DBX | ||
| 2,784.460 | ||
| -8.8140 | -0.0032% | |
| ECONOMIC30 | ||
| 82.160 | ||
| -0.1080 | -0.0013% | |
| ESGQKEHATI | ||
| 101.041 | ||
| -0.1210 | -0.0012% | |
| ESGSKEHATI | ||
| 101.646 | ||
| -0.1120 | -0.0011% | |
| I-GRADE | ||
| 145.869 | ||
| -0.4900 | -0.0033% | |
| AUDRP | ||
| 12,478.670 | ||
| -6.0700 | -0.0486% | |
| EURRP | ||
| 20,015.670 | ||
| 3.4000 | 0.0170% | |
| JPYRP | ||
| 113.144 | ||
| 0.0313 | 0.0277% | |
| SINRP | ||
| 13,978.280 | ||
| -22.1900 | -0.1585% | |
| USDRP | ||
| 17,888.000 | ||
| -55.0000 | -0.3065% | |
